OCD Trial, Recruiting NCT07198594 Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07198594
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Obsessive Compulsive Disorder (OCD) based on standard medical criteria
  • You do not have associated tics or Tourette's Syndrome
  • You are between 18 and 60 years old and are right-handed
  • Your OCD is considered at least moderate in severity, based on a standard OCD rating scale score of 16 or above
  • Your medications have been stable for at least 4 weeks
  • Your OCD has not responded well enough to standard treatments — specifically, you have tried at least 2 standard OCD medications (such as SSRIs or clomipramine) at the right dose for long enough, or 1 such medication plus an add-on treatment (such as certain antipsychotics, lithium, or buspirone), without enough improvement
  • You have not received a specific type of brain stimulation therapy called rTMS in the past 6 months
  • You are willing and able to sign a consent form agreeing to take part
  • You have normal vision or vision that is fully corrected with glasses or contact lenses
  • You are able to complete the tests and tasks required by the study

Who may not be able to join:

  • You have significant memory or thinking difficulties (based on a standard cognitive test score below 24)
  • Your main diagnosis is something other than OCD (though mild depression alongside OCD may be acceptable)
  • You have also been diagnosed with schizophrenia or another psychotic disorder, bipolar disorder, or a current substance use or dependency problem
  • You have had significant thoughts of harming yourself or serious suicidal tendencies in the past year
  • You have a vision or hearing problem that cannot be corrected and would prevent you from completing study assessments
  • You have metal implants in your body, such as a pacemaker or a stent
  • There are any medical, psychological, personal, or practical circumstances that could put you at risk or make it difficult for you to safely take part (confirm with trial site)
  • You are unlikely to follow the study requirements reliably
  • You have claustrophobia (fear of enclosed spaces)
  • You have a personal or family history of epilepsy
  • You are pregnant or breastfeeding; women who could become pregnant must have a negative pregnancy test before starting and must use an approved form of contraception during the study
  • You have serious problems with the functioning of a major organ such as your heart, lungs, liver, or kidneys, or have unstable vital signs
  • You have increased pressure in your skull or eyes, or a condition called glaucoma
  • You have a history of, or currently have, a neurological condition affecting the brain or nervous system — this includes stroke, brain infections, certain progressive brain diseases, Parkinson's disease, dementia, traumatic brain injury, brain tumours, thyroid or other hormonal disorders affecting the brain, or other conditions that affect brain function (confirm with trial site for the full list)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13585960699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Registry
ClinicalTrials.gov
Start date
3 July 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

OCD Symptom Severity Assessed by Y-BOCS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov